22,23-dihydrobrassicasterol

22,23-dihydrobrassicasterol is a lipid of Sterol Lipids (ST) class. 22,23-dihydrobrassicasterol is associated with abnormalities such as Diabetes, Macular degeneration, Drusen, Systemic disease and Diabetes Mellitus. The involved functions are known as cholesterol metabolism, Synthesis, Intestinal Absorption, Liver function and cholesterol absorption. 22,23-dihydrobrassicasterol often locates in Back and Cell membrane. The associated genes with 22,23-dihydrobrassicasterol are apolipoprotein E-3. The related lipids are Total cholesterol, campesterol, lathosterol, Fatty Acids, Nonesterified and Cholesterol, Dietary.

Cross Reference

Introduction

To understand associated biological information of 22,23-dihydrobrassicasterol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 22,23-dihydrobrassicasterol?

22,23-dihydrobrassicasterol is suspected in Diabetes, Macular degeneration, Drusen, Systemic disease, Diabetes Mellitus, Liver diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 22,23-dihydrobrassicasterol

MeSH term MeSH ID Detail
Coronary Disease D003327 70 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Hyperlipidemias D006949 73 associated lipids
Hypolipoproteinemias D007009 9 associated lipids
Xanthomatosis D014973 17 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Total 7

PubChem Associated disorders and diseases

What pathways are associated with 22,23-dihydrobrassicasterol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 22,23-dihydrobrassicasterol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 22,23-dihydrobrassicasterol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 22,23-dihydrobrassicasterol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 22,23-dihydrobrassicasterol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 22,23-dihydrobrassicasterol?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 22,23-dihydrobrassicasterol

Download all related citations
Per page 10 20 50 100 | Total 313
Authors Title Published Journal PubMed Link
pmid:
Baker VA et al. Safety evaluation of phytosterol esters. Part 1. Assessment of oestrogenicity using a combination of in vivo and in vitro assays. 1999 Food Chem. Toxicol. pmid:10069478
Choe S et al. The Arabidopsis dwarf1 mutant is defective in the conversion of 24-methylenecholesterol to campesterol in brassinosteroid biosynthesis. 1999 Plant Physiol. pmid:10069828
Gylling H et al. Serum sterols during stanol ester feeding in a mildly hypercholesterolemic population. 1999 J. Lipid Res. pmid:10191283
Strom SS et al. Phytoestrogen intake and prostate cancer: a case-control study using a new database. 1999 Nutr Cancer pmid:10227039
Jones PJ et al. Cholesterol-lowering efficacy of a sitostanol-containing phytosterol mixture with a prudent diet in hyperlipidemic men. 1999 Am. J. Clin. Nutr. pmid:10357732
Noguchi T et al. Arabidopsis det2 is defective in the conversion of (24R)-24-methylcholest-4-En-3-one to (24R)-24-methyl-5alpha-cholestan-3-one in brassinosteroid biosynthesis. 1999 Plant Physiol. pmid:10398719
Bortolomeazzi R et al. Mass spectrometry characterization of the 5alpha-, 7alpha-, and 7beta-hydroxy derivatives of beta-sitosterol, campesterol, stigmasterol, and brassicasterol. 1999 J. Agric. Food Chem. pmid:10552610
Mensenkamp AR et al. Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver. 1999 J. Biol. Chem. pmid:10585451
Nguyen TT et al. Cholesterol-lowering effect of stanol ester in a US population of mildly hypercholesterolemic men and women: a randomized controlled trial. 1999 Mayo Clin. Proc. pmid:10593347